Latest Us Market News

MedAdvisor reports a significant revenue decline in FY25 amid US program delays but strengthens its balance sheet through a capital raise and ANZ business sale. The company signals a strategic pivot with potential US business divestment on the horizon.

EVE Health Group has completed its acquisition of Nextract, raised $1 million to fund manufacturing, and achieved key regulatory and commercial milestones for its pharmaceutical products targeting erectile dysfunction and dysmenorrhea.

Ionic Rare Earths advances its rare earths strategy with major UK government funding, Brazilian JV progress, and US expansion talks amid China export controls.

Control Bionics capped a record FY25 with 15% revenue growth, driven by US market gains and expanding NeuroNode and NeuroStrip technologies. The company also achieved a US profitability milestone and is close to finalizing key distribution partnerships.

Stakk Limited has reported a remarkable 262% year-on-year increase in annual recurring revenue receipts, driven by its Embedded Finance services in the US and Australia. The company is poised to broaden its offerings with new client wins and the upcoming launch of Embedded Lending capabilities.

Silver Mines Limited progresses regulatory approvals for its flagship Bowdens Silver Project in NSW while acquiring promising US assets, enhancing its exploration pipeline with minimal upfront costs.

RMA Global Limited has reported its first full year of positive operating cash flow alongside accelerating revenue growth in both the US and ANZ markets, driven by strategic product launches and expanded brokerage partnerships.

Flight Centre Travel Group has reported a record total transaction value of $24.5 billion for FY25, yet underlying profits fell slightly short of expectations amid geopolitical tensions and regional challenges. The company is banking on new AI and loyalty initiatives to drive future growth.

Novatti Group reported a record $14.3 million quarterly revenue in Q4 FY25, marking a clear shift back to growth after streamlining operations and focusing on higher-margin opportunities. The company’s platform upgrade and leadership changes set the stage for stronger financial performance ahead.

PainChek Limited has secured a A$7.5 million placement to fuel its international expansion, with US FDA clearance for its adult pain assessment app expected imminently. The company reports strong license growth and a 26% revenue increase year-on-year.

TZ Limited has landed a significant bulk order from Microsoft and completed the Keyvision acquisition, positioning itself for a strong FY26 despite recent US market challenges.

Syrah Resources has resumed production at its Balama graphite mine after a year-long halt and is advancing sales at its US Vidalia anode material facility, supported by new US tariffs on Chinese imports and a $70 million equity raise.